IMARC Group’s report titled “Peripheral Artery Disease Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“, The global peripheral artery disease market size reached US$ 4.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 6.3 Billion by 2028, exhibiting a growth rate (CAGR) of 5.94% during 2023-2028.
Peripheral Artery Disease (PAD), also known as peripheral vascular disease, is a common circulatory condition that affects the blood vessels outside the heart and brain, primarily the arteries in the limbs. It occurs when these arteries become narrowed or blocked due to the accumulation of fatty deposits, known as plaque, within the arterial walls. This buildup of plaque restricts the flow of oxygen-rich blood to the extremities, typically the legs, causing a range of symptoms and potential complications. Common symptoms of PAD include intermittent claudication, which is pain, cramping, or discomfort in the legs during physical activity, especially while walking or climbing stairs. As the disease progresses, individuals may experience persistent pain, numbness, or weakness in the affected limbs, even at rest. PAD can also lead to poor wound healing in the legs and feet, increasing the risk of infections and non-healing ulcers.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/peripheral-artery-disease-market/requestsample
Peripheral Artery Disease Market Trends and Drivers:
The Peripheral Artery Disease (PAD) market is witnessing notable trends and drivers that are shaping its growth trajectory. One significant trend is the increasing prevalence of PAD, primarily driven by the aging population and the rising incidence of risk factors such as diabetes, hypertension, and obesity. This demographic shift has expanded the patient pool in need of PAD diagnosis and treatment, consequently boosting the demand for related healthcare products and services. Technological advancements in the diagnosis and management of PAD are also contributing to market growth. Non-invasive imaging techniques, such as ultrasound and magnetic resonance angiography, are becoming more accessible and accurate in detecting PAD, allowing for early diagnosis and intervention. Moreover, advancements in minimally invasive endovascular procedures, like angioplasty and stenting, are providing effective treatment options with reduced risks and quicker recovery times for patients. The increasing focus on preventive healthcare and lifestyle modifications is another driver of the PAD market. Healthcare initiatives aimed at raising awareness about the importance of early PAD detection and adopting healthier habits to reduce the risk of PAD development are gaining traction. This preventive approach is expected to reduce the overall burden of PAD and promote better patient outcomes.
Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Type:
- Peripheral Angioplasty Balloons
- Peripheral Stents
- Peripheral Catheters
- Inferior Vena Cava (IVC) Filters
- Plaque Modification Devices
- Hemodynamic Flow Alteration Devices
- Peripheral Accessories
Breakup by End User:
- Hospitals
- Specialty Clinics
- Others
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Competitive Landscape with Key Player:
- Abbott Laboratories
- AngioDynamics
- Braun Melsungen AG
- Becton Dickinson and Company
- Biotronik SE & Co. KG
- Boston Scientific Corporation
- Cardinal Health Inc.
- Cook Medical LLC
- Koninklijke Philips N.V.
- Medtronic plc and Terumo Corporation
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
Email: [email protected]
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Follow us on Twitter: @imarcglobal
